au.\*:("PETER, Barbara")
Results 1 to 6 of 6
Selection :
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536PETER, Barbara; GLEIXNER, Karoline V; PICKL, Winfried F et al.Haematologica (Roma). 2011, Vol 96, Num 5, pp 672-680, issn 0390-6078, 9 p.Article
Expression of activins C and E induces apoptosis in human and rat hepatoma cellsVEJDA, Susanne; ERLACH, Natascha; PETER, Barbara et al.Carcinogenesis (New York. Print). 2003, Vol 24, Num 11, pp 1801-1809, issn 0143-3334, 9 p.Article
Fiberoptic intubation and laryngeal morbidity : A randomized controlled trialHEIDEGGER, Thomas; STARZYK, Lukas; VILLIGER, Cornelia R et al.Anesthesiology (Philadelphia). 2007, Vol 107, Num 4, pp 585-590, issn 0003-3022, 6 p.Article
The coffee components kahweol and cafestol induce γ-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the ratHUBER, Wolfgang W; SCHARF, Gerlinde; ROSSMANITH, Walter et al.Archives of toxicology. 2002, Vol 75, Num 11-12, pp 685-694, issn 0340-5761Article
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligandGHANIM, Viviane; HERRMANN, Harald; PICKL, Winfried F et al.Blood. 2012, Vol 119, Num 18, pp 4242-4252, issn 0006-4971, 11 p.Article
Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536GLEIXNER, Karoline V; FERENC, Veronika; VALENT, Peter et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 4, pp 1513-1523, issn 0008-5472, 11 p.Article